# FDA Inspection 1200803 - Cantor BioConnect, Inc. - March 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/647c9f97-73c9-4f91-8247-8f680d3c99f6
Source feed: FDA_Inspections

> FDA Inspection 1200803 for Cantor BioConnect, Inc. on March 22, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200803
- Company Name: Cantor BioConnect, Inc.
- Inspection Date: 2023-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1309164 - 2026-03-24](https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/606f4ba3-5651-413a-b5b8-df5cceefc700)
- [FDA Inspection 1200803 - 2023-03-22](https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/9de06b39-78c0-472c-a6ee-526e4a7e53f0)

Company: https://www.keypedia.com/companies/cantor-bioconnect-inc/981435e7-15fc-4730-bb5e-ceb13c11f367

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d